| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatitis, Acute Necrotizing | 11 | 2022 | 171 | 5.690 |
Why?
|
| Debridement | 8 | 2020 | 488 | 3.080 |
Why?
|
| Cholecystectomy, Laparoscopic | 7 | 2021 | 227 | 2.550 |
Why?
|
| Drainage | 7 | 2022 | 1135 | 2.190 |
Why?
|
| Altitude Sickness | 8 | 2011 | 80 | 2.180 |
Why?
|
| Altitude | 7 | 2011 | 139 | 1.740 |
Why?
|
| Pancreatitis | 6 | 2022 | 1052 | 1.680 |
Why?
|
| Cholecystitis, Acute | 4 | 2018 | 66 | 1.490 |
Why?
|
| Pulmonary Edema | 5 | 2011 | 423 | 1.410 |
Why?
|
| Choledocholithiasis | 2 | 2021 | 48 | 1.000 |
Why?
|
| Embolization, Therapeutic | 3 | 2022 | 1416 | 0.990 |
Why?
|
| Gallstones | 3 | 2020 | 281 | 0.990 |
Why?
|
| Duodenal Ulcer | 1 | 2022 | 123 | 0.950 |
Why?
|
| Intestinal Fistula | 5 | 2021 | 150 | 0.930 |
Why?
|
| Malnutrition | 5 | 2020 | 618 | 0.890 |
Why?
|
| Endoscopy | 4 | 2020 | 1745 | 0.870 |
Why?
|
| Intraoperative Complications | 9 | 2020 | 1194 | 0.840 |
Why?
|
| Mountaineering | 4 | 2010 | 44 | 0.820 |
Why?
|
| Cutaneous Fistula | 4 | 2021 | 84 | 0.810 |
Why?
|
| Nutrition Therapy | 2 | 2019 | 98 | 0.800 |
Why?
|
| Length of Stay | 18 | 2022 | 6273 | 0.790 |
Why?
|
| Enterocolitis, Pseudomembranous | 3 | 2017 | 263 | 0.780 |
Why?
|
| Enteral Nutrition | 9 | 2022 | 720 | 0.760 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2021 | 480 | 0.760 |
Why?
|
| Intensive Care Units | 15 | 2022 | 3422 | 0.760 |
Why?
|
| Gallbladder | 3 | 2020 | 309 | 0.720 |
Why?
|
| Appendicitis | 4 | 2021 | 627 | 0.700 |
Why?
|
| Hemorrhage | 6 | 2021 | 3208 | 0.680 |
Why?
|
| Pancreas | 5 | 2020 | 1706 | 0.660 |
Why?
|
| Cholecystostomy | 1 | 2017 | 44 | 0.650 |
Why?
|
| Abdominal Abscess | 2 | 2015 | 145 | 0.650 |
Why?
|
| Intracranial Hypertension | 2 | 2011 | 179 | 0.640 |
Why?
|
| Critical Illness | 14 | 2022 | 2471 | 0.640 |
Why?
|
| Cholecystectomy | 3 | 2017 | 390 | 0.630 |
Why?
|
| Cholecystitis | 4 | 2020 | 186 | 0.600 |
Why?
|
| Surgical Wound Infection | 5 | 2021 | 1488 | 0.600 |
Why?
|
| Fasciitis, Necrotizing | 3 | 2021 | 81 | 0.590 |
Why?
|
| Surgical Procedures, Operative | 8 | 2020 | 1884 | 0.580 |
Why?
|
| Intracranial Pressure | 2 | 2008 | 323 | 0.570 |
Why?
|
| Cholelithiasis | 1 | 2017 | 417 | 0.560 |
Why?
|
| Pancreatic Fistula | 1 | 2016 | 160 | 0.550 |
Why?
|
| Digestive System Surgical Procedures | 5 | 2021 | 567 | 0.530 |
Why?
|
| Optic Nerve | 2 | 2008 | 557 | 0.520 |
Why?
|
| Bile Duct Diseases | 1 | 2014 | 99 | 0.520 |
Why?
|
| Soft Tissue Infections | 3 | 2021 | 150 | 0.510 |
Why?
|
| Postoperative Complications | 13 | 2021 | 15035 | 0.510 |
Why?
|
| Hospital Mortality | 11 | 2021 | 5117 | 0.510 |
Why?
|
| Myelin Sheath | 2 | 2008 | 651 | 0.500 |
Why?
|
| Abdominal Injuries | 4 | 2022 | 352 | 0.500 |
Why?
|
| Ultrasonography | 5 | 2015 | 5913 | 0.490 |
Why?
|
| Trauma Centers | 9 | 2022 | 833 | 0.490 |
Why?
|
| Glasgow Outcome Scale | 1 | 2013 | 109 | 0.490 |
Why?
|
| Radiography, Abdominal | 2 | 2020 | 587 | 0.470 |
Why?
|
| Wounds and Injuries | 7 | 2020 | 2399 | 0.470 |
Why?
|
| Retrospective Studies | 45 | 2022 | 71151 | 0.460 |
Why?
|
| Meckel Diverticulum | 1 | 2011 | 35 | 0.450 |
Why?
|
| Bezoars | 1 | 2011 | 26 | 0.440 |
Why?
|
| Teichoic Acids | 1 | 2012 | 74 | 0.440 |
Why?
|
| Male | 98 | 2022 | 351848 | 0.440 |
Why?
|
| Abdomen | 4 | 2019 | 1097 | 0.430 |
Why?
|
| Middle Aged | 76 | 2021 | 215428 | 0.430 |
Why?
|
| Abdominal Wound Closure Techniques | 2 | 2022 | 33 | 0.410 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2012 | 126 | 0.410 |
Why?
|
| Erythrocyte Transfusion | 3 | 2022 | 517 | 0.400 |
Why?
|
| Pneumonia | 1 | 2022 | 2071 | 0.400 |
Why?
|
| Emergencies | 6 | 2022 | 1133 | 0.400 |
Why?
|
| Humans | 118 | 2022 | 709431 | 0.400 |
Why?
|
| Polyurethanes | 3 | 2015 | 98 | 0.390 |
Why?
|
| Critical Care | 8 | 2021 | 2490 | 0.390 |
Why?
|
| Inflammation | 6 | 2018 | 9948 | 0.380 |
Why?
|
| Restraint, Physical | 1 | 2010 | 183 | 0.370 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2015 | 790 | 0.370 |
Why?
|
| Alkaline Phosphatase | 6 | 2021 | 896 | 0.370 |
Why?
|
| Female | 90 | 2022 | 377269 | 0.370 |
Why?
|
| Nutritional Status | 6 | 2020 | 1545 | 0.360 |
Why?
|
| Laparotomy | 4 | 2022 | 476 | 0.360 |
Why?
|
| Retroperitoneal Space | 2 | 2019 | 163 | 0.350 |
Why?
|
| Bupivacaine | 1 | 2012 | 424 | 0.350 |
Why?
|
| Aged | 53 | 2022 | 162592 | 0.350 |
Why?
|
| Emergency Medical Services | 4 | 2021 | 1740 | 0.350 |
Why?
|
| Adult | 56 | 2022 | 212298 | 0.340 |
Why?
|
| Emergency Service, Hospital | 7 | 2022 | 7410 | 0.340 |
Why?
|
| Intestinal Obstruction | 1 | 2011 | 415 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2020 | 20307 | 0.340 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 1020 | 0.330 |
Why?
|
| Referral and Consultation | 2 | 2017 | 3448 | 0.310 |
Why?
|
| Blood Proteins | 1 | 2012 | 1135 | 0.310 |
Why?
|
| Nepal | 4 | 2008 | 269 | 0.300 |
Why?
|
| Pain, Postoperative | 2 | 2018 | 1598 | 0.300 |
Why?
|
| Hypophosphatemia | 2 | 2017 | 93 | 0.300 |
Why?
|
| Patient Transfer | 1 | 2013 | 762 | 0.290 |
Why?
|
| General Surgery | 4 | 2018 | 1651 | 0.290 |
Why?
|
| Duodenum | 2 | 2022 | 479 | 0.290 |
Why?
|
| Nerve Block | 1 | 2012 | 634 | 0.290 |
Why?
|
| Hospitalization | 10 | 2020 | 9632 | 0.280 |
Why?
|
| Neck Injuries | 2 | 2018 | 142 | 0.280 |
Why?
|
| Exsanguination | 2 | 2015 | 27 | 0.280 |
Why?
|
| Anesthetics, Local | 1 | 2012 | 988 | 0.280 |
Why?
|
| Injury Severity Score | 8 | 2021 | 988 | 0.270 |
Why?
|
| Intestine, Small | 1 | 2011 | 1235 | 0.270 |
Why?
|
| Heart Rate | 5 | 2015 | 4107 | 0.270 |
Why?
|
| Emergency Treatment | 2 | 2018 | 508 | 0.260 |
Why?
|
| Acute Disease | 5 | 2022 | 7201 | 0.260 |
Why?
|
| Thoracic Injuries | 3 | 2021 | 240 | 0.260 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 2262 | 0.250 |
Why?
|
| Treatment Outcome | 22 | 2022 | 61963 | 0.250 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2007 | 362 | 0.250 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2007 | 492 | 0.250 |
Why?
|
| Hemostatic Techniques | 2 | 2014 | 123 | 0.240 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2022 | 46 | 0.240 |
Why?
|
| Wounds, Gunshot | 2 | 2021 | 532 | 0.230 |
Why?
|
| Hemoperitoneum | 1 | 2022 | 39 | 0.230 |
Why?
|
| Thromboembolism | 2 | 2021 | 986 | 0.230 |
Why?
|
| Patient Admission | 2 | 2020 | 1405 | 0.230 |
Why?
|
| Triage | 3 | 2021 | 910 | 0.230 |
Why?
|
| Fournier Gangrene | 1 | 2021 | 22 | 0.220 |
Why?
|
| Vasodilator Agents | 1 | 2007 | 1013 | 0.220 |
Why?
|
| Risk Factors | 25 | 2021 | 70264 | 0.220 |
Why?
|
| Risk Assessment | 12 | 2021 | 23519 | 0.220 |
Why?
|
| Severity of Illness Index | 8 | 2015 | 16161 | 0.220 |
Why?
|
| Hepatic Artery | 1 | 2022 | 248 | 0.220 |
Why?
|
| Brain Injuries | 1 | 2013 | 1905 | 0.210 |
Why?
|
| Indiana | 1 | 2020 | 91 | 0.210 |
Why?
|
| Aged, 80 and over | 19 | 2021 | 58752 | 0.210 |
Why?
|
| Portal System | 1 | 2020 | 55 | 0.210 |
Why?
|
| Hospital Costs | 1 | 2007 | 986 | 0.200 |
Why?
|
| Panniculitis | 1 | 2020 | 46 | 0.200 |
Why?
|
| Prospective Studies | 19 | 2021 | 50734 | 0.200 |
Why?
|
| Blood Transfusion | 3 | 2021 | 1245 | 0.200 |
Why?
|
| Cervical Vertebrae | 2 | 2018 | 965 | 0.200 |
Why?
|
| Abdominal Wall | 1 | 2021 | 144 | 0.200 |
Why?
|
| Laparoscopy | 1 | 2011 | 1990 | 0.190 |
Why?
|
| Rib Fractures | 1 | 2020 | 106 | 0.190 |
Why?
|
| Aspartate Aminotransferases | 1 | 2021 | 416 | 0.190 |
Why?
|
| Bilirubin | 1 | 2021 | 394 | 0.180 |
Why?
|
| Rectus Abdominis | 1 | 2019 | 97 | 0.180 |
Why?
|
| Crowding | 1 | 2020 | 144 | 0.180 |
Why?
|
| Nutrition Assessment | 2 | 2019 | 731 | 0.180 |
Why?
|
| Colon, Sigmoid | 1 | 2019 | 118 | 0.180 |
Why?
|
| Dietary Proteins | 4 | 2018 | 971 | 0.180 |
Why?
|
| Cholangiography | 1 | 2018 | 188 | 0.180 |
Why?
|
| Video-Assisted Surgery | 1 | 2018 | 48 | 0.170 |
Why?
|
| Ileostomy | 1 | 2019 | 119 | 0.170 |
Why?
|
| Sepsis | 1 | 2012 | 2438 | 0.170 |
Why?
|
| Diagnostic Techniques, Digestive System | 1 | 2018 | 49 | 0.170 |
Why?
|
| Protein-Energy Malnutrition | 2 | 2018 | 194 | 0.170 |
Why?
|
| Training Support | 1 | 2018 | 121 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 5 | 2002 | 2003 | 0.170 |
Why?
|
| Acetazolamide | 2 | 2008 | 100 | 0.170 |
Why?
|
| Protein Deficiency | 1 | 2017 | 66 | 0.170 |
Why?
|
| Duodenoscopy | 1 | 2017 | 48 | 0.170 |
Why?
|
| Time Factors | 10 | 2020 | 41295 | 0.170 |
Why?
|
| Hospitals, Community | 1 | 2020 | 334 | 0.170 |
Why?
|
| Psoas Muscles | 1 | 2018 | 68 | 0.170 |
Why?
|
| Diverticulitis, Colonic | 1 | 2019 | 123 | 0.170 |
Why?
|
| Wounds, Penetrating | 1 | 2019 | 306 | 0.160 |
Why?
|
| Refeeding Syndrome | 1 | 2016 | 13 | 0.160 |
Why?
|
| United States | 20 | 2021 | 67177 | 0.160 |
Why?
|
| Intestinal Diseases | 1 | 2021 | 502 | 0.160 |
Why?
|
| Bile | 1 | 2018 | 302 | 0.160 |
Why?
|
| After-Hours Care | 1 | 2017 | 104 | 0.150 |
Why?
|
| Catheters | 1 | 2019 | 334 | 0.150 |
Why?
|
| Osteoblasts | 3 | 2001 | 1204 | 0.150 |
Why?
|
| Prealbumin | 1 | 2018 | 209 | 0.150 |
Why?
|
| Acrylic Resins | 1 | 2016 | 156 | 0.150 |
Why?
|
| Digestive System Fistula | 1 | 2015 | 9 | 0.150 |
Why?
|
| Predictive Value of Tests | 8 | 2021 | 15316 | 0.150 |
Why?
|
| Sensitivity and Specificity | 7 | 2018 | 14895 | 0.150 |
Why?
|
| Appendectomy | 2 | 2018 | 382 | 0.150 |
Why?
|
| Plasma | 1 | 2019 | 565 | 0.150 |
Why?
|
| Burns | 1 | 2007 | 1781 | 0.150 |
Why?
|
| Dura Mater | 4 | 2002 | 295 | 0.150 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1720 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2011 | 3280 | 0.140 |
Why?
|
| Survival Rate | 6 | 2021 | 13363 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 2 | 2021 | 1155 | 0.140 |
Why?
|
| Quality Improvement | 5 | 2019 | 3712 | 0.140 |
Why?
|
| Arthritis | 1 | 2020 | 650 | 0.140 |
Why?
|
| Delayed Diagnosis | 2 | 2015 | 410 | 0.140 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 1062 | 0.140 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 2656 | 0.140 |
Why?
|
| Serum Albumin | 1 | 2018 | 687 | 0.140 |
Why?
|
| Gelatin | 1 | 2016 | 222 | 0.140 |
Why?
|
| Wounds, Stab | 1 | 2015 | 79 | 0.140 |
Why?
|
| Massachusetts | 4 | 2021 | 8754 | 0.140 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 1308 | 0.130 |
Why?
|
| Viscoelastic Substances | 1 | 2014 | 20 | 0.130 |
Why?
|
| Efficiency, Organizational | 1 | 2019 | 697 | 0.130 |
Why?
|
| Pneumothorax | 2 | 2020 | 384 | 0.130 |
Why?
|
| Glasgow Coma Scale | 4 | 2020 | 546 | 0.130 |
Why?
|
| Leukocyte Count | 1 | 2018 | 1677 | 0.130 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2018 | 756 | 0.130 |
Why?
|
| Fees and Charges | 1 | 2015 | 193 | 0.130 |
Why?
|
| Logistic Models | 8 | 2016 | 13622 | 0.130 |
Why?
|
| Truth Disclosure | 1 | 2018 | 439 | 0.130 |
Why?
|
| Databases, Factual | 9 | 2020 | 7801 | 0.130 |
Why?
|
| Arteriovenous Malformations | 1 | 2016 | 378 | 0.130 |
Why?
|
| Energy Intake | 3 | 2018 | 2127 | 0.120 |
Why?
|
| Radar | 1 | 2012 | 8 | 0.120 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2013 | 69 | 0.120 |
Why?
|
| Reflex, Pupillary | 1 | 2013 | 60 | 0.120 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2013 | 66 | 0.120 |
Why?
|
| Cholangitis | 1 | 2014 | 103 | 0.120 |
Why?
|
| Hemostatics | 1 | 2015 | 221 | 0.120 |
Why?
|
| Cohort Studies | 6 | 2022 | 39650 | 0.120 |
Why?
|
| Calcifediol | 1 | 2014 | 173 | 0.120 |
Why?
|
| Mycetoma | 1 | 2012 | 11 | 0.120 |
Why?
|
| Colon | 1 | 2021 | 1772 | 0.120 |
Why?
|
| Oxygen Consumption | 2 | 2010 | 1933 | 0.120 |
Why?
|
| Benchmarking | 2 | 2017 | 914 | 0.120 |
Why?
|
| Gangrene | 2 | 2015 | 88 | 0.120 |
Why?
|
| Parenteral Nutrition | 1 | 2017 | 641 | 0.120 |
Why?
|
| Ischemia | 1 | 2021 | 1916 | 0.110 |
Why?
|
| Spinal Injuries | 1 | 2015 | 298 | 0.110 |
Why?
|
| Fluoroscopy | 1 | 2016 | 904 | 0.110 |
Why?
|
| Preoperative Care | 2 | 2019 | 2368 | 0.110 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3163 | 0.110 |
Why?
|
| Warfarin | 1 | 2020 | 1437 | 0.110 |
Why?
|
| Diverticulitis | 1 | 2014 | 163 | 0.110 |
Why?
|
| Violence | 1 | 2018 | 892 | 0.110 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3276 | 0.110 |
Why?
|
| Peritonitis | 1 | 2014 | 380 | 0.110 |
Why?
|
| Diagnosis, Differential | 5 | 2020 | 13362 | 0.110 |
Why?
|
| Lung Diseases, Fungal | 1 | 2012 | 131 | 0.110 |
Why?
|
| Spinal Fractures | 1 | 2018 | 688 | 0.110 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1887 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2022 | 2481 | 0.110 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 520 | 0.100 |
Why?
|
| Risk Adjustment | 1 | 2015 | 589 | 0.100 |
Why?
|
| Communicable Diseases | 1 | 2018 | 801 | 0.100 |
Why?
|
| Cranial Sutures | 2 | 2001 | 85 | 0.100 |
Why?
|
| Incidence | 9 | 2020 | 20587 | 0.100 |
Why?
|
| Comorbidity | 6 | 2021 | 10621 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2017 | 1513 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2019 | 1067 | 0.100 |
Why?
|
| Age Factors | 5 | 2021 | 18954 | 0.100 |
Why?
|
| Patient Discharge | 3 | 2021 | 2963 | 0.100 |
Why?
|
| Thoracotomy | 1 | 2012 | 364 | 0.100 |
Why?
|
| Fascia | 2 | 2022 | 134 | 0.100 |
Why?
|
| Craniocerebral Trauma | 1 | 2014 | 475 | 0.100 |
Why?
|
| Ethanol | 1 | 2016 | 1252 | 0.100 |
Why?
|
| Blast Injuries | 1 | 2013 | 285 | 0.100 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 986 | 0.100 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 1644 | 0.100 |
Why?
|
| Patient Rights | 1 | 2010 | 127 | 0.100 |
Why?
|
| Entropy | 3 | 2015 | 208 | 0.090 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2014 | 569 | 0.090 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 1104 | 0.090 |
Why?
|
| Respiration, Artificial | 2 | 2017 | 2428 | 0.090 |
Why?
|
| Young Adult | 10 | 2021 | 56163 | 0.090 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2014 | 590 | 0.090 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 1544 | 0.090 |
Why?
|
| Shock | 2 | 2021 | 322 | 0.090 |
Why?
|
| Follow-Up Studies | 7 | 2020 | 39394 | 0.090 |
Why?
|
| Drug Administration Schedule | 2 | 2020 | 5112 | 0.090 |
Why?
|
| Brain Concussion | 1 | 2020 | 1277 | 0.090 |
Why?
|
| Mortality | 1 | 2020 | 2794 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2785 | 0.090 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2008 | 96 | 0.090 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 1673 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2020 | 4250 | 0.090 |
Why?
|
| Radiography, Interventional | 1 | 2015 | 1097 | 0.080 |
Why?
|
| Multivariate Analysis | 6 | 2020 | 12517 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 2030 | 0.080 |
Why?
|
| Pandemics | 3 | 2022 | 6922 | 0.080 |
Why?
|
| Hospitals | 2 | 2017 | 3232 | 0.080 |
Why?
|
| Clostridium Infections | 1 | 2014 | 497 | 0.080 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2007 | 90 | 0.080 |
Why?
|
| Thoracic Vertebrae | 1 | 2012 | 615 | 0.080 |
Why?
|
| Burn Units | 1 | 2007 | 131 | 0.080 |
Why?
|
| Operating Rooms | 3 | 2019 | 791 | 0.080 |
Why?
|
| Internship and Residency | 2 | 2018 | 5527 | 0.080 |
Why?
|
| Anesthesia, General | 1 | 2014 | 1086 | 0.080 |
Why?
|
| Bed Rest | 1 | 2007 | 79 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1891 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 1473 | 0.080 |
Why?
|
| Nifedipine | 1 | 2007 | 222 | 0.080 |
Why?
|
| Skin | 1 | 2020 | 4319 | 0.080 |
Why?
|
| Adolescent | 8 | 2020 | 85327 | 0.070 |
Why?
|
| Albuterol | 1 | 2007 | 211 | 0.070 |
Why?
|
| Skull | 2 | 2001 | 808 | 0.070 |
Why?
|
| Patient Selection | 1 | 2018 | 4322 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 7497 | 0.070 |
Why?
|
| Prognosis | 5 | 2015 | 29148 | 0.070 |
Why?
|
| Hospitals, Urban | 1 | 2007 | 514 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2823 | 0.070 |
Why?
|
| Collagen | 4 | 2001 | 2693 | 0.070 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 1318 | 0.070 |
Why?
|
| Iliac Artery | 1 | 2007 | 385 | 0.070 |
Why?
|
| Recurrence | 1 | 2017 | 8279 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2017 | 5136 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2015 | 2316 | 0.060 |
Why?
|
| Sulfones | 1 | 2007 | 452 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 1350 | 0.060 |
Why?
|
| Stents | 1 | 2016 | 3299 | 0.060 |
Why?
|
| Hemodynamics | 2 | 2011 | 4199 | 0.060 |
Why?
|
| Osteocalcin | 2 | 2001 | 279 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2016 | 8512 | 0.060 |
Why?
|
| Necrosis | 2 | 2018 | 1632 | 0.060 |
Why?
|
| Phosphates | 2 | 2017 | 784 | 0.060 |
Why?
|
| Child | 5 | 2015 | 73998 | 0.060 |
Why?
|
| Abdominal Pain | 2 | 2020 | 1046 | 0.060 |
Why?
|
| Sialoglycoproteins | 2 | 2002 | 379 | 0.060 |
Why?
|
| Purines | 1 | 2007 | 604 | 0.060 |
Why?
|
| Mass Screening | 1 | 2019 | 5186 | 0.060 |
Why?
|
| Reference Values | 2 | 2010 | 5070 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3070 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2001 | 12468 | 0.060 |
Why?
|
| Travel | 1 | 2008 | 730 | 0.060 |
Why?
|
| Osteopontin | 2 | 2002 | 341 | 0.060 |
Why?
|
| Hospitals, Teaching | 1 | 2007 | 1157 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 1332 | 0.060 |
Why?
|
| Extracellular Matrix | 2 | 2001 | 1796 | 0.060 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2002 | 628 | 0.060 |
Why?
|
| Curriculum | 1 | 2015 | 3312 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 3301 | 0.060 |
Why?
|
| Propensity Score | 2 | 2020 | 1739 | 0.060 |
Why?
|
| Radiology | 1 | 2015 | 1906 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2014 | 3005 | 0.060 |
Why?
|
| African Americans | 2 | 2007 | 5194 | 0.060 |
Why?
|
| Health Surveys | 2 | 2014 | 4032 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 15548 | 0.050 |
Why?
|
| Blood Component Transfusion | 1 | 2022 | 124 | 0.050 |
Why?
|
| Femoral Artery | 1 | 2007 | 950 | 0.050 |
Why?
|
| Amputation | 1 | 2007 | 800 | 0.050 |
Why?
|
| Leg | 1 | 2007 | 1161 | 0.050 |
Why?
|
| Boston | 3 | 2021 | 9409 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2020 | 2963 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2007 | 3000 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 1895 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2011 | 1484 | 0.050 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3890 | 0.050 |
Why?
|
| Prone Position | 1 | 2021 | 179 | 0.050 |
Why?
|
| Hypoalbuminemia | 1 | 2020 | 60 | 0.050 |
Why?
|
| Neuromuscular Blockade | 1 | 2021 | 144 | 0.050 |
Why?
|
| Pressure Ulcer | 1 | 2021 | 153 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 4381 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2007 | 2503 | 0.050 |
Why?
|
| Reoperation | 2 | 2020 | 4155 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17347 | 0.050 |
Why?
|
| Creatine Kinase | 1 | 2021 | 713 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2000 | 623 | 0.050 |
Why?
|
| Intraoperative Period | 1 | 2020 | 547 | 0.050 |
Why?
|
| Adenoviridae | 2 | 2001 | 1138 | 0.050 |
Why?
|
| Tokyo | 1 | 2018 | 24 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2020 | 706 | 0.040 |
Why?
|
| Linear Models | 1 | 2008 | 6012 | 0.040 |
Why?
|
| Pneumonia, Bacterial | 1 | 2021 | 315 | 0.040 |
Why?
|
| Hungary | 1 | 2017 | 82 | 0.040 |
Why?
|
| Gene Transfer Techniques | 2 | 2001 | 1303 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2007 | 1986 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 388 | 0.040 |
Why?
|
| Wound Healing | 2 | 2017 | 2792 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2018 | 537 | 0.040 |
Why?
|
| Hernia, Ventral | 1 | 2018 | 136 | 0.040 |
Why?
|
| Osteogenesis | 2 | 2002 | 1280 | 0.040 |
Why?
|
| Hospitals, General | 1 | 2020 | 717 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2017 | 6563 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 556 | 0.040 |
Why?
|
| Time | 1 | 2017 | 530 | 0.040 |
Why?
|
| Steroids | 1 | 2021 | 879 | 0.040 |
Why?
|
| Cytokines | 2 | 2001 | 7214 | 0.040 |
Why?
|
| Piperazines | 1 | 2007 | 2606 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2021 | 1005 | 0.040 |
Why?
|
| Rats | 6 | 2002 | 25068 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18384 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2015 | 41195 | 0.040 |
Why?
|
| Risk Management | 1 | 2019 | 574 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 961 | 0.040 |
Why?
|
| Colectomy | 1 | 2020 | 653 | 0.040 |
Why?
|
| Germany | 1 | 2017 | 829 | 0.030 |
Why?
|
| Neutrophils | 2 | 2018 | 3865 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2001 | 2880 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 2002 | 1643 | 0.030 |
Why?
|
| APACHE | 1 | 2015 | 270 | 0.030 |
Why?
|
| Animals | 10 | 2014 | 170647 | 0.030 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2018 | 393 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2001 | 877 | 0.030 |
Why?
|
| Abbreviated Injury Scale | 1 | 2014 | 47 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 11384 | 0.030 |
Why?
|
| Head | 1 | 2020 | 834 | 0.030 |
Why?
|
| Antimalarials | 1 | 2021 | 854 | 0.030 |
Why?
|
| Starvation | 1 | 2014 | 139 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2683 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 3169 | 0.030 |
Why?
|
| Cells, Cultured | 5 | 2002 | 20303 | 0.030 |
Why?
|
| Swine | 2 | 2014 | 5743 | 0.030 |
Why?
|
| Vital Signs | 1 | 2015 | 134 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2020 | 10603 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 2015 | 227 | 0.030 |
Why?
|
| Polymerization | 1 | 2014 | 167 | 0.030 |
Why?
|
| Brazil | 1 | 2017 | 1137 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 464 | 0.030 |
Why?
|
| Angiography | 1 | 2019 | 1672 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2001 | 13351 | 0.030 |
Why?
|
| ROC Curve | 1 | 2021 | 3537 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2015 | 486 | 0.030 |
Why?
|
| Netherlands | 1 | 2017 | 2071 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2017 | 803 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2022 | 2477 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 1933 | 0.030 |
Why?
|
| Jejunum | 1 | 2014 | 505 | 0.030 |
Why?
|
| Organ Size | 1 | 2018 | 2320 | 0.030 |
Why?
|
| Permeability | 1 | 2014 | 786 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 22944 | 0.030 |
Why?
|
| Ileum | 1 | 2014 | 561 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 1753 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 2017 | 910 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2020 | 1080 | 0.030 |
Why?
|
| Liver | 2 | 2020 | 7629 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 1617 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2021 | 4903 | 0.030 |
Why?
|
| India | 1 | 2017 | 2001 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2574 | 0.030 |
Why?
|
| Multiple Trauma | 1 | 2014 | 361 | 0.030 |
Why?
|
| Electrocardiography | 2 | 2015 | 6390 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2013 | 904 | 0.030 |
Why?
|
| Clinical Competence | 2 | 2018 | 4618 | 0.030 |
Why?
|
| Prevalence | 2 | 2020 | 14849 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 1232 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1569 | 0.030 |
Why?
|
| Nontherapeutic Human Experimentation | 1 | 2010 | 24 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2002 | 291 | 0.030 |
Why?
|
| Environment, Controlled | 1 | 2010 | 48 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2018 | 2822 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2000 | 3577 | 0.020 |
Why?
|
| Health Services Research | 1 | 2018 | 1838 | 0.020 |
Why?
|
| Leukocytes | 1 | 2018 | 2103 | 0.020 |
Why?
|
| Mice | 3 | 2014 | 80950 | 0.020 |
Why?
|
| Resuscitation | 1 | 2014 | 646 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2002 | 8581 | 0.020 |
Why?
|
| Registries | 2 | 2015 | 8019 | 0.020 |
Why?
|
| Cell Division | 3 | 2002 | 4787 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2015 | 1148 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 1019 | 0.020 |
Why?
|
| Anesthetics | 1 | 2014 | 527 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 1827 | 0.020 |
Why?
|
| Morbidity | 1 | 2014 | 1694 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 3823 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2015 | 1470 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2017 | 2048 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2018 | 6515 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2010 | 377 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2014 | 2379 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2017 | 12426 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2539 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19470 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2017 | 21874 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2930 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2002 | 654 | 0.020 |
Why?
|
| Self Report | 1 | 2018 | 3412 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2015 | 1158 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 731 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 3952 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2020 | 2947 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 7988 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12008 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2001 | 11749 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 3691 | 0.020 |
Why?
|
| Colitis | 1 | 2014 | 1138 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 4383 | 0.020 |
Why?
|
| Cross Infection | 1 | 2014 | 1411 | 0.020 |
Why?
|
| Opioid-Related Disorders | 1 | 2018 | 1825 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 4237 | 0.020 |
Why?
|
| Students, Medical | 1 | 2015 | 1734 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 11673 | 0.010 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2002 | 44 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2018 | 4131 | 0.010 |
Why?
|
| Pregnancy | 2 | 2019 | 26811 | 0.010 |
Why?
|
| Autocrine Communication | 1 | 2002 | 185 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 10019 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 2001 | 506 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2001 | 180 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2002 | 285 | 0.010 |
Why?
|
| Vitamin D | 1 | 2014 | 3117 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2000 | 765 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2002 | 577 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 863 | 0.010 |
Why?
|
| Gene Expression | 2 | 2002 | 8069 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13298 | 0.010 |
Why?
|
| Mandible | 1 | 2000 | 712 | 0.010 |
Why?
|